Ningning Luo

Jiangsu Province Key Laboratory For Inflammation And Molecular Drug Target
Nantong, 226001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Development of a Hypoxia-Triggered Supramolecular Nanoplatform for Synergistic Hypoxia Alleviation and Amplified Photodynamic Cancer Therapy.

Development of a Hypoxia-Triggered Supramolecular Nanoplatform for Synergistic Hypoxia Alleviation and Amplified Photodynamic Cancer Therapy.

Journal: Molecules (Basel, Switzerland)

Published: June 11, 2026

Heterozygous Germline Fanconi Anemia-Related Gene Mutations Increase Susceptibility to Germ Cell Tumors.

Heterozygous Germline Fanconi Anemia-Related Gene Mutations Increase Susceptibility to Germ Cell Tumors.

Journal: JCO precision oncology

Published: September 04, 2025

The Mutation Patterns of MET Gene in Lung Cancer and Brain Tumors: Clinical and Therapeutic Implications.

The Mutation Patterns of MET Gene in Lung Cancer and Brain Tumors: Clinical and Therapeutic Implications.

Journal: Cancer medicine

Published: June 17, 2025

Mutation patterns and prognostic potentiality of homologous recombination repair genes in gliomas.

Mutation patterns and prognostic potentiality of homologous recombination repair genes in gliomas.

Journal: BMC cancer

Published: February 22, 2025

Clinical and genomic features of Lynch syndrome differ by tumor site and disease spectrum.

Clinical and genomic features of Lynch syndrome differ by tumor site and disease spectrum.

Journal: Nature communications

Published: February 16, 2025

Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms.

Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms.

Journal: BMC cancer

Published: February 07, 2025

Dual PTCH2 mutation [Ser391*, Leu104Pro]: unveiling a potential new genetic susceptibility factor for glioma development.

Dual PTCH2 mutation [Ser391*, Leu104Pro]: unveiling a potential new genetic susceptibility factor for glioma development.

Journal: Investigational new drugs

Published: November 19, 2024

Research progress on Pb-induced neurotoxicity through glial cells

Research progress on Pb-induced neurotoxicity through glial cells

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: October 20, 2024

Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma.

Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma.

Journal: Cellular and molecular neurobiology

Published: July 26, 2024

Predictive value of ZFHX4 mutation for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer and melanoma.

Predictive value of ZFHX4 mutation for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer and melanoma.

Journal: Investigational new drugs

Published: July 10, 2024

Genetic and clinical characteristics of genetic tumor syndromes in the central nervous system cancers: Implications for clinical practice.

Genetic and clinical characteristics of genetic tumor syndromes in the central nervous system cancers: Implications for clinical practice.

Journal: iScience

Published: May 28, 2024

A patient with heterochronous double primary tumor of basal ganglia germ cell tumors followed by diffuse hemispheric glioma: a case report.

A patient with heterochronous double primary tumor of basal ganglia germ cell tumors followed by diffuse hemispheric glioma: a case report.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: April 19, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026